Related Experiment Videos

Meso-tetra-(4-sulfonatophenyl)-porphine of low neurotoxicity

E Strelecková1, D Kodetová, P Poucková

  • 1Clinic of Neurology, Charles University, Prague, Czech Republic.

Sbornik Lekarsky
|January 1, 1995
PubMed

Insights

The acute toxicity of meso-tetra-(4-sulfonatophenyl)-porphine (TPPS4) was evaluated in rodents. TPPS4 demonstrated low toxicity, with high LD50 values and no significant neurotoxicity, supporting its potential clinical use.

Area of Science:

  • Pharmacology
  • Toxicology
  • Biochemistry

Background:

  • Meso-tetra-(4-sulfonatophenyl)-porphine (TPPS4) is a photosensitizer with potential therapeutic applications.
  • Assessing the safety profile of TPPS4 is crucial for its clinical translation.

Purpose of the Study:

  • To determine the acute toxicity and neurotoxicity of a specially purified TPPS4 preparation in animal models.
  • To evaluate the safety of TPPS4 for potential clinical applications.

Main Methods:

  • Acute toxicity was assessed by intravenous administration of TPPS4 in DBA/2 mice and Wistar rats to determine LD50 values.
  • Neurotoxicity was evaluated by measuring motor nerve conduction velocity in rats and rabbits.
  • Histological and electron microscopic analyses were performed to examine potential tissue damage.

Main Results:

  • The LD50 of TPPS4 was determined to be 352.5 mg/kg in mice and 574.9 mg/kg in rats.
  • No signs of neurotoxicity were observed, even at a dose of 150 mg/kg.
  • Histological examination revealed only minimal and sporadic axonal changes.

Conclusions:

  • The specially purified TPPS4 preparation exhibits low acute toxicity in rodents.
  • TPPS4 does not appear to possess significant neurotoxic properties.
  • The favorable safety profile warrants further consideration of TPPS4 for clinical applications.

Related Concept Videos